The Ozempic®, Wegovy®, Mounjaro® shortages affect patients’ health.
Town & Country Compounding provides alternatives they need.
“Do you have Ozempic®? Do you have Wegovy®?”
At Town & Country Compounding, we get asked this question every day due to the nationwide shortages of these drugs.
High Quality, Fast Turnaround GLP-1 Injections During the FDA Shortage
Compounded Semaglutide GLP 1: How We Help Patients – Patient Video Instructions
These injectable drugs, (Ozempic®, and Wegovy®), utilized in diabetes and/or weight loss, are often on the FDA drug shortage list which makes access for patients very limited. When the drugs appear on the FDA drug shortage list, sterile compounding pharmacies are allowed to compound semaglutide injection, yet they are not considered generics.
As the media has recently reported, it is very important to use only a high-quality compounding pharmacy and research the pharmacy where your sterile compounded medications come from. The compounding pharmacy should be using an outside lab to test sterility and endotoxins of the semaglutide made in their lab.
The FDA has specific guidelines about compounding semaglutide; and as an accredited compounding pharmacy, Town & Country Compounding strictly adheres to those guidelines.
Doctors Trust Town & Country Compounding for High-Quality Compounded Medications
Where you get compounded medications makes a big difference in health outcomes.
Unlike commercial drugs from a retail pharmacy (that will have the same quality no matter where you buy them), the quality and effectiveness of compounded medications can vary widely from pharmacy to pharmacy.
Do you know how your sterile compounded medicines are made?
See our sterile compounding labs and accreditations.
What is the difference with these injectable drugs?
- Semaglutide (the active ingredient in Ozempic® and Wegovy®) works as an agonist on only the GLP-1(Glucagon-like Peptide-1) receptor.
- Tirzepatide (the active ingredient in Mounjaro®) — dual receptor agonist, works on the GLP-1 receptor and the GIP (Glucose Dependent Insulinotropic Polypeptide, also known as Gastric Inhibiting Polypeptide) receptor. *Activation of both types of receptors enhances the glucose-lowering effects which may provide additional benefits in terms of weight loss and blood sugar control.
Semaglutide
Semaglutide primarily stimulates the GLP-1 receptor, leading to increased insulin release, reduced glucagon secretion, slowed gastric emptying, and increased feelings of fullness, and it is used to improve blood sugar control and, in higher doses, for weight management.
*Activation of the GLP-1 receptor leads to several beneficial effect with semaglutide
- Increased insulin release
- Reduced glucagon secretion
- Slowed gastric emptying and increased feelings of fullness
- Decreased hunger through satiety pathways
- Up-modulates fat utilization
- Reduced ghrelin levels in the stomach/gut
It's easy to prescribe semaglutide with Town & Country Compounding
Nutritional Support for Patients on Ozempic®, and Wegovy® (Semaglutide )
Patients using Ozempic®,and Wegovy®, compounded semaglutide, can find helpful nutritional support products at Town & Country Compounding.
Deciding which vitamins and supplements to use during the weight loss process is always a popular topic of discussion. Whether patients are diabetic or not, they can benefit from being aware of options for nutrition support.
A professional supplement line (available only to medical professionals), Ortho Molecular, has developed a protocol to help support patients who are using Ozempic®, and Wegovy® and compounded semaglutide injection.
Read our step-by-step guide to semaglutide nutritional support.
